Skip to content

Portman Square Capital LLP: ITRI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Portman Square Capital LLP on ITRI, newest first. How the timeline and the estimate are built.

Portman Square Capital LLP held 0 ITRI shares at 2025-12-31 per its 13F-HR filed 2026-01-23.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -30,209 shares

    13F-HR 0001172661-26-000284 filed by Portman Square Capital LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 30,209 shares
    Change vs previous 13F +30,209 shares

    0.5% of the 13F portfolio, value $3,762,833.

    13F-HR 0001172661-25-004304 filed by Portman Square Capital LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 0 shares
    Change vs previous 13F -4,154 shares

    13F-HR 0001172661-25-001561 filed by Portman Square Capital LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  4. period ended2024-12-31
    13F 4,154 shares
    Change vs previous 13F +92 shares

    0.09% of the 13F portfolio, value $451,041.

    13F-HR 0001172661-25-000225 filed by Portman Square Capital LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 4,062 shares
    Change vs previous 13F not available

    0.14% of the 13F portfolio, value $433,862.

    13F-HR 0001172661-24-004266 filed by Portman Square Capital LLP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).